Antiphospholipid Antibodies and the Risk of Thromboembolic Events in Valvular Heart Disease

Bulckaen, Helene G.; Puisieux, Francois L.; Bulckaen, Emmanuel D.; Di Pompeo, Christophe; Bouillanne, Olivier M.; Watel, Annie A.; Fauchais, Anne-Laure M.; De Groote, Pascal; Millaire, Alain
March 2003
Mayo Clinic Proceedings;Mar2003, Vol. 78 Issue 3, p294
Academic Journal
Investigates the role of antiphospholipid antibodies in subsequent thromboembolic events and mortality in a prospective follow-up of patients with sever, nonspecific valvular heart disease. Presence of anticardiolipin antibodies and lupus anticoagulant; Cause of death; Use of multivariate Cox analysis.


Related Articles

  • Non-criteria manifestations of antiphospholipid syndrome. Erkan, D.; Lockshin, M. D. // Lupus;Apr2010, Vol. 19 Issue 4, p424 

    Only few studies have addressed the pathogenesis and treatment of the non-criteria manifestations of antiphospholipid antibodies (aPL) such as thrombocytopenia, nephropathy, cardiac valve disease, cognitive dysfunction, skin ulcers, or diffuse pulmonary hemorrhage. There is no consensus on the...

  • [Anti-β[sub 2] Glycoprotein I–β[sub 2] Glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases. Biasiolo, A.; Rampazzo, P.; Brocco, T.; Barbero, F.; Rosato, A.; Pengo, V. // Lupus;1999, Vol. 8 Issue 2, p121 

    Antiphospholipid syndrome (APS) is defined by the presence of aPL antibodies in patients with thromboembolic phenomena. Some antiphospholipid (aPL) antibodies, such as those directed against β[sub 2]-glycoprotein I (β[sub 2]GPI), are associated with thromboembolism, possess Lupus...

  • Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review. Mattos, Priscila; Santiago, Mittermayer // Clinical Rheumatology;Feb2011, Vol. 30 Issue 2, p165 

    Over the last few years, several studies in patients with systemic lupus erythematosus (SLE) have demonstrated an association between valvulopathy, including Libman-Sacks endocarditis (LS) and the presence of antiphospholipid antibodies (aPL), suggesting a role of these antibodies in the...

  • A rarely seen syndrome in rehabilitation of hemiplegia: antiphospholipid antibody-negative Sneddon’s syndrome. Akbal, Ayla; Kurtaran, Aydan; Selçuk, Barın; Ersöz, Murat; Akyüz, Müfit // Rheumatology International;Sep2010, Vol. 30 Issue 11, p1489 

    Sneddon’s syndrome is a rarely seen disorder and it is characterized by livedo reticularis (LR) and neurologic findings. Some systematic findings may also be seen with neurologic and cutaneous findings. In this case, we aimed to present a 28-year-old female patient with diffuse LR,...

  • Familial coexistence of primary antiphospholipid syndrome and factor V[sub Leiden]. Schütt, M.; Klüter, H.; Hagedorn-Greiwe, M.; Fehm, H.L.; Wiedemann, G.J. // Lupus;1998, Vol. 7 Issue 3, p176 

    The antiphospholipid syndrome (APS) is an autoimmune thrombophilic disorder in which thromboembolism and thrombocytopenia occur. The antiphospholipid antibodies in these patients may cause acquired activated protein C resistance, whereas hereditary activated protein C resistance results from a...

  • Platelet activation and turnover in the primary antiphospholipid syndrome. Joseph, J.E.; Donohoe, S.; Harrison, P.; Mackie, I.J.; Machin, S.J. // Lupus;1998, Vol. 7 Issue 5, p333 

    Thromboembolism is a common occurrence in patients with the antiphospholipid syndrome (APS). The mechanism responsible for this phenomenon is unclear; there are several theories. One possibility is that a pathogenic interaction exists between antiphospholipid antibodies and platelets, leading to...

  • The use of D-dimers in the diagnosis of occult pulmonary emboli in HIV pulmonary disease � two case reports. Winston, A.; Baker, R. W.; Nelson, M.; Gazzard, B. // International Journal of STD & AIDS;Oct2000, Vol. 11 Issue 10, p675 

    Pulmonary thromboembolism is not considered a common cause of morbidity in HIV disease. Although anti-phospholipid antibodies are often seen in HIV disease, they are not associated with an increased thrombotic risk. Computed tomographic (CT) pulmonary angiography has been described as the...

  • Interpretation of laboratory data and need for reference laboratories. Pengo, V; Denas, G; Banzato, A; Bison, E; Bracco, A; Visentin, MS; Hoxha, A; Ruffatti, A // Lupus;Jul2012, Vol. 21 Issue 7, p732 

    A single positive laboratory test among those exploring the presence of antiphospholipid antibodies is not associated with thromboembolic events and does not identify patients with antiphospholipid syndrome. On the other hand, more than one laboratory test positive, and in particular all three...

  • Should we be testing for antiphospholipid antibodies in unexplained pulmonary thromboembolism and atherosclerosis at autopsy? Bierton, Christopher; Langlois, Neil // Forensic Science, Medicine & Pathology;Dec2013, Vol. 9 Issue 4, p573 

    The article discusses whether antiphospholipid antibodies with autopsy should be tested to explain deaths due to pulmonary thromboembolism and atherosclerosis after surgery. It states that the antiphospholipid antibodies represent risk for death due to deep vein pulmonary thromboembolism or...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics